Submitted by elizabethwu1 on Thu, 09/12/2013 - 3:53pm NCT01602393 CHF 5074 United States Tuesday, May 1, 2012 – Wednesday, November 13, 2013 51 Phase 2 Mild Cognitive Impairment Thursday, September 12, 2013 Chiesi Pharmaceuticals Inc. Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by elizabethwu1 on
Submitted by elizabethwu1 on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.